CareRay Digital Medical Technology Co., Ltd. (SHA:688607)
China · Delayed Price · Currency is CNY 52.03
+0.92 (1.80%)
At close: Feb 13, 2026
SHA:688607 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 319.4 | 288.88 | 267.68 | 197.4 | 328.05 | 325.6 |
Other Revenue | 9.22 | 9.22 | 6.06 | 7.18 | 13.93 | 13.62 |
| 328.62 | 298.1 | 273.74 | 204.57 | 341.98 | 339.22 | |
Revenue Growth (YoY) | 14.17% | 8.90% | 33.81% | -40.18% | 0.81% | 44.63% |
Cost of Revenue | 214.03 | 185.59 | 172.69 | 140.88 | 185.19 | 193.21 |
Gross Profit | 114.59 | 112.51 | 101.05 | 63.69 | 156.79 | 146.01 |
Selling, General & Admin | 65.78 | 58.18 | 54.96 | 52.91 | 46.5 | 42.79 |
Research & Development | 37.05 | 43.72 | 44.6 | 44.52 | 31.87 | 25.62 |
Other Operating Expenses | -1.65 | -0.58 | -0.44 | -0.58 | -1.57 | -1.88 |
Operating Expenses | 111.33 | 103.87 | 100.5 | 97.2 | 80.6 | 62.26 |
Operating Income | 3.25 | 8.63 | 0.56 | -33.51 | 76.19 | 83.75 |
Interest Expense | -0.71 | -0.75 | -0.51 | -0.37 | -0.21 | -0.34 |
Interest & Investment Income | 1.03 | 8.01 | 10.22 | 12.51 | 18.9 | 4.35 |
Currency Exchange Gain (Loss) | 1.04 | 1.04 | 2.97 | 10.27 | -1.26 | -5.61 |
Other Non Operating Income (Expenses) | -3.08 | 1.06 | -1.12 | -0.55 | -0.44 | -0.31 |
EBT Excluding Unusual Items | 1.53 | 17.99 | 12.12 | -11.65 | 93.17 | 81.83 |
Gain (Loss) on Sale of Investments | -0.03 | -1.15 | 1.41 | 0.11 | -0.34 | 1.57 |
Gain (Loss) on Sale of Assets | 0 | -0 | 0.19 | -0.04 | - | -0.08 |
Asset Writedown | -0.45 | -0.02 | - | - | - | - |
Legal Settlements | -0.01 | -0.01 | - | - | - | - |
Other Unusual Items | 0.72 | 0.87 | 1.58 | 2.67 | 3.44 | 4.66 |
Pretax Income | 1.76 | 17.69 | 15.3 | -8.91 | 96.28 | 87.98 |
Income Tax Expense | -3.43 | 0.01 | -0.11 | -3.23 | 11.23 | 12.87 |
Earnings From Continuing Operations | 5.19 | 17.68 | 15.41 | -5.68 | 85.05 | 75.11 |
Minority Interest in Earnings | 0.22 | -0.02 | 0 | 0.05 | 0.04 | 0.03 |
Net Income | 5.41 | 17.65 | 15.41 | -5.63 | 85.09 | 75.14 |
Net Income to Common | 5.41 | 17.65 | 15.41 | -5.63 | 85.09 | 75.14 |
Net Income Growth | -78.08% | 14.54% | - | - | 13.23% | 55.96% |
Shares Outstanding (Basic) | 87 | 88 | 91 | 94 | 86 | 66 |
Shares Outstanding (Diluted) | 87 | 88 | 91 | 94 | 86 | 66 |
Shares Change (YoY) | -9.21% | -2.64% | -3.38% | 9.18% | 30.39% | -0.13% |
EPS (Basic) | 0.06 | 0.20 | 0.17 | -0.06 | 0.99 | 1.14 |
EPS (Diluted) | 0.06 | 0.20 | 0.17 | -0.06 | 0.99 | 1.14 |
EPS Growth | -75.86% | 17.65% | - | - | -13.16% | 56.16% |
Free Cash Flow | -130.7 | -73.59 | -21.71 | -55.89 | 17.46 | 64.23 |
Free Cash Flow Per Share | -1.50 | -0.83 | -0.24 | -0.60 | 0.20 | 0.97 |
Dividend Per Share | 0.061 | 0.061 | 0.054 | - | - | 0.340 |
Dividend Growth | 12.96% | 12.96% | - | - | - | - |
Gross Margin | 34.87% | 37.74% | 36.92% | 31.13% | 45.85% | 43.04% |
Operating Margin | 0.99% | 2.90% | 0.20% | -16.38% | 22.28% | 24.69% |
Profit Margin | 1.65% | 5.92% | 5.63% | -2.75% | 24.88% | 22.15% |
Free Cash Flow Margin | -39.77% | -24.69% | -7.93% | -27.32% | 5.11% | 18.93% |
EBITDA | 3.24 | 11.26 | 6.71 | -27 | 82.3 | 89.72 |
EBITDA Margin | 0.98% | 3.78% | 2.45% | -13.20% | 24.06% | 26.45% |
D&A For EBITDA | -0.02 | 2.63 | 6.15 | 6.51 | 6.11 | 5.98 |
EBIT | 3.25 | 8.63 | 0.56 | -33.51 | 76.19 | 83.75 |
EBIT Margin | 0.99% | 2.90% | 0.20% | -16.38% | 22.28% | 24.69% |
Effective Tax Rate | - | 0.06% | - | - | 11.66% | 14.63% |
Revenue as Reported | 328.62 | 298.1 | 273.74 | 204.57 | 341.98 | 339.22 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.